HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally. It develops the Harbour Mice Platform, which generates human monoclonal antibodies in two heavy and two light chain H2L2 and heavy chain formats. The company is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds and inhibits the neonatal fragment crystallizable receptor for treating myasthenia gravis; Porustobart HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4 for treating melanoma, colorectal cancer, hepatocellular carcinoma, and neuroendocrine neoplasm. It is developing HBM7020 for treating hepatocellular carcinoma and autoimmune diseases; HBM9378 for the treatment of asthma and chronic obstructive pulmonary disease; and HBM1020, HBM7022, HBM7008, HBM9027, HBM7004, and HBM9033 for treating solid tumors. The company has a strategic collaboration with Evinova to apply AI and digital technologies to enhance the efficiency of biologics development. The company was incorporated in 2016 and is based in Suzhou, the People's Republic of China.
Frequently asked questions
What sector does HBM Holdings Limited (HBMHF) operate in?
HBM Holdings Limited belongs to the Healthcare sector and operates in the Biotechnology industry.
What is HBM Holdings Limited (HBMHF) current stock price?
As of the latest data, HBM Holdings Limited stock price is $1.56, with a previous close of $1.56.
What is HBM Holdings Limited (HBMHF) current market capitalization?
HBM Holdings Limited market cap is approximately 1.29 billion.
What is HBM Holdings Limited (HBMHF) Earnings Per Share (EPS)?
The trailing EPS is $0.12.
What is HBM Holdings Limited (HBMHF) Price-to-Earnings (P/E) ratio?
HBM Holdings Limited current P/E ratio is 13.
What is HBM Holdings Limited (HBMHF) EBITDA?
HBM Holdings Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 69.30 million.
Does HBM Holdings Limited (HBMHF) pay dividends?
No. HBM Holdings Limited does not pay a dividend.
What is HBM Holdings Limited (HBMHF) beta (volatility) score?
HBM Holdings Limited has a beta of 1.378, suggesting it is more volatile than the market.
